Sonya Del Tredici and John Keenan
Sonya Del Tredici and John Keenan
9. Psilocybin for Alcohol Use Disorder
9. Psilocybin for Alcohol Use Disorder
9. Psilocybin for Alcohol Use Disorder
Monday 24th October 2022
Explore psilocybin therapy for alcohol use disorder, prescription refusals by Wal-Mart and CVS, and gabapentin's role in overdose deaths with Drs. Del Tredici and Keenan.
39 minutes
Informative
Thought-provoking
Engaging
Educational
Supportive
About this podcast
Author:
Sonya Del Tredici and John Keenan
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Episodes:
56 (View all)
Do you want to link to this podcast?
Get the buttons here!Psilocybin Therapy: A New Frontier in Alcohol Use Disorder Treatment
So the article is called percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder, and it was from jama psychiatry.
Imagine finding a new ally in the battle against alcohol use disorder. In this episode of 'Addiction Medicine Journal Club', Dr. Sonya Del Tredici and Dr. John Keenan take a deep dive into the promising world of psilocybin-assisted psychotherapy. They dissect a groundbreaking study published in JAMA Psychiatry, which shows a significant reduction in heavy drinking days for those treated with psilocybin compared to a placebo. The hosts explore how this psychedelic compound could revolutionize treatment options for alcohol dependence.
But that's not all. The episode also touches on the latest buzz in the pharmacy world, with Wal-Mart and CVS making headlines for their refusal to fill certain telemedicine prescriptions. This controversial move raises important questions about access to medication and the future of telehealth. Additionally, Drs. Del Tredici and Keenan delve into the role of gabapentin in overdose deaths and its effectiveness for treating neuropathic pain.
They review recent findings from the CDC and Cochrane Database, providing a comprehensive look at this widely prescribed medication. The conversation doesn't stop there. The hosts also bring up the concept of Mendelian randomization, discussing its implications for understanding the relationship between alcohol use disorder and cardiovascular disease. This episode is packed with insights and expert opinions that are sure to leave you thinking long after it ends.
Whether you're a healthcare professional or someone interested in the latest addiction treatment research, this episode offers valuable information and thought-provoking discussions.